rs17588387

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_014844.5(TECPR2):​c.-72-211A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0272 in 152,272 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.027 ( 74 hom., cov: 32)

Consequence

TECPR2
NM_014844.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.100

Publications

0 publications found
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 49
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 14-102376439-A-G is Benign according to our data. Variant chr14-102376439-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 672764.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0272 (4144/152272) while in subpopulation SAS AF = 0.0428 (206/4818). AF 95% confidence interval is 0.038. There are 74 homozygotes in GnomAd4. There are 2055 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 74 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014844.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECPR2
NM_014844.5
MANE Select
c.-72-211A>G
intron
N/ANP_055659.2O15040-1
TECPR2
NM_001172631.3
c.-72-211A>G
intron
N/ANP_001166102.1O15040-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECPR2
ENST00000359520.12
TSL:1 MANE Select
c.-72-211A>G
intron
N/AENSP00000352510.7O15040-1
TECPR2
ENST00000558678.1
TSL:1
c.-72-211A>G
intron
N/AENSP00000453671.1O15040-2
TECPR2
ENST00000856897.1
c.-72-211A>G
intron
N/AENSP00000526956.1

Frequencies

GnomAD3 genomes
AF:
0.0272
AC:
4144
AN:
152154
Hom.:
74
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00741
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.0384
Gnomad ASJ
AF:
0.0455
Gnomad EAS
AF:
0.0342
Gnomad SAS
AF:
0.0427
Gnomad FIN
AF:
0.0406
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0312
Gnomad OTH
AF:
0.0402
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0272
AC:
4144
AN:
152272
Hom.:
74
Cov.:
32
AF XY:
0.0276
AC XY:
2055
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00739
AC:
307
AN:
41550
American (AMR)
AF:
0.0384
AC:
587
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0455
AC:
158
AN:
3472
East Asian (EAS)
AF:
0.0341
AC:
177
AN:
5188
South Asian (SAS)
AF:
0.0428
AC:
206
AN:
4818
European-Finnish (FIN)
AF:
0.0406
AC:
430
AN:
10604
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0312
AC:
2123
AN:
68034
Other (OTH)
AF:
0.0407
AC:
86
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
211
421
632
842
1053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0270
Hom.:
9
Bravo
AF:
0.0263
Asia WGS
AF:
0.0450
AC:
155
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.76
DANN
Benign
0.51
PhyloP100
0.10
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17588387; hg19: chr14-102842776; API